Medical decision making / (Record no. 90999)

000 -LEADER
fixed length control field 11175cam a2200673 i 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250705115645.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu---unuuu
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 250705t20242024njum ob u001 0 eng
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781119627807
Qualifying information paperback
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781119627722
Qualifying information electronic book
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1119627729
Qualifying information electronic book
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781119627845
Qualifying information electronic book
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1119627842
Qualifying information electronic book
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781119627876
Qualifying information electronic book
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1119627877
Qualifying information electronic book
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)1389488752
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title eng
042 ## - AUTHENTICATION CODE
Authentication code pcc
050 04 - LIBRARY OF CONGRESS CALL NUMBER
Classification number R723.5
Item number .M38 2024
050 04 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RT48
Item number .S69 2024
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number WB 142.5
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number WB 141.5
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.07/5
Edition number 23/eng/20230703
100 1# - MAIN ENTRY--PERSONAL NAME
Preferred name for the person Sox, Harold C.,
Authority record control number https://id.loc.gov/authorities/names/n86038233
Relator term author.
245 10 - TITLE STATEMENT
Title Medical decision making /
Statement of responsibility, etc Harold C. Sox, Michael C. Higgins, Douglas K. Owens, Gillian Sanders Schmidler.
250 ## - EDITION STATEMENT
Edition statement Third edition.
264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc Hoboken, NJ :
Name of publisher, distributor, etc John Wiley & Sons, Inc.,
Date of publication, distribution, etc 2024.
264 #4 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Date of publication, distribution, etc ©2024.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (xiv, 348 pages) :
Other physical details illustrations.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent.
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia.
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier.
340 ## - PHYSICAL MEDIUM
Source rdacc
Authority record control number or standard number http://rdaregistry.info/termList/RDAColourContent/1003.
500 ## - GENERAL NOTE
General note Includes bibliographical references and index.
505 0# - CONTENTS
Formatted contents note Table of Contents<br/>Foreword xi<br/><br/>Preface xiii<br/><br/>1 Introduction 1<br/><br/>1.1 How may I be thorough yet efficient when considering the possible causes of my patient’s problems? 1<br/><br/>1.2 How do I characterize the information I have gathered during the medical interview and physical examination? 1<br/><br/>1.3 How do I interpret new diagnostic information? 3<br/><br/>1.4 How do I select the appropriate diagnostic test? 4<br/><br/>1.5 How do I choose among several risky treatment alternatives? 4<br/><br/>2 Differential diagnosis 5<br/><br/>2.1 An introduction 5<br/><br/>2.2 How clinicians make a diagnosis 5<br/><br/>2.3 The principles of hypothesis- driven differential diagnosis 8<br/><br/>2.4 An extended example 14<br/><br/>Bibliography 16<br/><br/>3 Probability: quantifying uncertainty 18<br/><br/>3.1 Uncertainty and probability in medicine 18<br/><br/>3.2 How to determine a probability 21<br/><br/>3.3 Sources of error in using personal experience to estimate the probability 23<br/><br/>3.4 The role of empirical evidence in quantifying uncertainty 30<br/><br/>3.5 Limitations of published studies of disease prevalence 35<br/><br/>3.6 Taking the special characteristics of the patient into account when determining probabilities 36<br/><br/>Bibliography 37<br/><br/>4 Interpreting new information: Bayes’ theorem 38<br/><br/>4.1 Introduction 38<br/><br/>4.2 Conditional probability defined 40<br/><br/>4.3 Bayes’ theorem 41<br/><br/>4.4 The odds ratio form of Bayes’ theorem 45<br/><br/>4.5 Lessons to be learned from using Bayes’ theorem 50<br/><br/>4.6 The assumptions of Bayes’ theorem 52<br/><br/>4.7 Using Bayes’ theorem to interpret a sequence of tests 54<br/><br/>4.8 Using Bayes’ theorem when many diseases are under consideration 55<br/><br/>Bibliography 57<br/><br/>5 Measuring the accuracy of clinical findings 58<br/><br/>5.1 A language for describing test results 58<br/><br/>5.2 The measurement of diagnostic test performance 62<br/><br/>5.3 How to measure diagnostic test performance: a hypothetical example 67<br/><br/>5.4 Pitfalls of predictive value 69<br/><br/>5.5 How to perform a high quality study of diagnostic test performance 70<br/><br/>5.6 Spectrum bias in the measurement of test performance 74<br/><br/>5.7 When to be concerned about inaccurate measures of test performance 79<br/><br/>5.8 Test results as a continuous variable: the ROC curve 81<br/><br/>5.9 Combining data from studies of test performance: the systematic review and meta- analysis 87<br/><br/>A.5.1 Appendix: derivation of the method for using an ROC curve to choose the definition of an abnormal test result 89<br/><br/>Bibliography 91<br/><br/>6 Decision trees – representing the structure of a decision problem 93<br/><br/>6.1 Introduction 93<br/><br/>6.2 Key concepts and terminology 93<br/><br/>6.3 Constructing the decision tree for a hypothetical decision problem 96<br/><br/>6.4 Constructing the decision tree for a medical decision problem 103<br/><br/>Epilogue 112<br/><br/>Bibliography 112<br/><br/>7 Decision tree analysis 113<br/><br/>7.1 Introduction 113<br/><br/>7.2 Folding- back operation 114<br/><br/>7.3 Sensitivity analysis 126<br/><br/>Epilogue 133<br/><br/>Bibliography 133<br/><br/>8 Outcome utility – representing risk attitudes 134<br/><br/>8.1 Introduction 134<br/><br/>8.2 What are risk attitudes? 135<br/><br/>8.3 Demonstration of risk attitudes in a medical context 136<br/><br/>8.4 General observations about outcome utilities 147<br/><br/>8.5 Determining outcome utilities – underlying concepts 151<br/><br/>Epilogue 157<br/><br/>Bibliography 158<br/><br/>9 Outcome utilities – clinical applications 159<br/><br/>9.1 Introduction 159<br/><br/>9.2 A parametric model for outcome utilities 160<br/><br/>9.3 Incorporating risk attitudes into clinical policies 172<br/><br/>9.4 Helping patients communicate their preferences 181<br/><br/>Epilogue 185<br/><br/>A.9.1 Exponential utility model parameter nomogram 186<br/><br/>Bibliography 188<br/><br/>10 Outcome utilities – adjusting for the quality of life 189<br/><br/>10.1 Introduction 189<br/><br/>10.2 Example – why the quality of life matters 190<br/><br/>10.3 Quality- lifetime tradeoff models 193<br/><br/>10.4 Quality- survival tradeoff models 203<br/><br/>10.5 What does it all mean? – an extended example 209<br/><br/>Epilogue 217<br/><br/>Bibliography 217<br/><br/>11 Survival models: representing uncertainty about the length of life 218<br/><br/>11.1 Introduction 218<br/><br/>11.2 Survival model basics 219<br/><br/>11.3 Medical example – survival after breast cancer recurrence 226<br/><br/>11.4 Exponential survival model 228<br/><br/>11.5 Actuarial survival models 232<br/><br/>11.6 Two- part survival models 235<br/><br/>Epilogue 247<br/><br/>Bibliography 247<br/><br/>12 Markov models 248<br/><br/>12.1 Introduction 248<br/><br/>12.2 Markov model basics 249<br/><br/>12.3 Determining transition probabilities 259<br/><br/>12.4 Markov model analysis – an overview 269<br/><br/>Epilogue 277<br/><br/>Bibliography 277<br/><br/>13 Selection and interpretation of diagnostic tests 278<br/><br/>13.1 Introduction 278<br/><br/>13.2 Four principles of decision making 279<br/><br/>13.3 The threshold probability for treatment 281<br/><br/>13.4 Threshold probabilities for testing 288<br/><br/>13.5 Clinical application of the threshold model of decision making 293<br/><br/>13.6 Accounting for the non- diagnostic effects of undergoing a test 296<br/><br/>13.7 Sensitivity analysis 298<br/><br/>13.8 Decision curve analysis 300<br/><br/>Bibliography 302<br/><br/>14 Medical decision analysis in practice: advanced methods 303<br/><br/>14.1 An overview of advanced modeling techniques 303<br/><br/>14.2 Use of medical decision- making concepts to analyze a policy problem: the cost- effectiveness of screening for HIV 305<br/><br/>14.3 Use of medical decision- making concepts to analyze a clinical diagnostic problem: strategies to diagnose tumors in the lung 313<br/><br/>14.4 Calibration and validation of decision models 317<br/><br/>14.5 Use of complex models for individual- patient decision making 319<br/><br/>Bibliography 321<br/><br/>15 Cost- effectiveness analysis 323<br/><br/>15.1 The clinician’s conflicting roles: patient advocate member of society and entrepreneur 323<br/><br/>15.2 Cost- effectiveness analysis: a method for comparing management strategies 325<br/><br/>15.3 Cost–benefit analysis: a method for measuring the net benefit of medical services 330<br/><br/>15.4 Methodological best practices for cost- effectiveness analysis 332<br/><br/>15.5 Reference case for cost- effectiveness analysis 333<br/><br/>15.6 Impact inventory for cataloguing consequences 334<br/><br/>15.7 Measuring the health effects of medical care 334<br/><br/>15.8 Measuring the costs of medical care 335<br/><br/>15.9 Interpretation of cost- effectiveness analysis and use in decision making 337<br/><br/>15.10 Limitations of cost- effectiveness analyses 337<br/><br/>Bibliography 338<br/><br/>Index 340
520 ## - SUMMARY, ETC.
Summary, etc "This volume addresses these needs. Chapters 1 and 2 set the stage: uncertainty is everywhere in clinical practice, yet clinical reasoning depends on logical deduction as exemplified by differential diagnosis. Chapters 3, 4, and 5 are about defining and navigating uncertainty: determining probability, updating probability, and the determinants of post-test probability, all basic tools of the clinician. Chapters 6 and 7 are about modeling the factors that shape decisions. Chapters 8-12 explore in-depth the measurement of utility, both the basics and the underlying theory. Topics include attitudes toward taking risks, the quality of life, and the length of life. The last three chapters are about making decisions: deciding when to treat, when to test, and when to wait (Chapter 13); the advanced modeling methods that inform policy. (Chapter 14); and cost-effectiveness analysis (Chapter 15)"--
Assigning source Provided by publisher.
545 0# - BIOGRAPHICAL OR HISTORICAL DATA
Biographical or historical note About the Authors<br/>Harold C. Sox is Emeritus Professor of Medicine and of the Dartmouth Institute at Geisel School of Medicine at Dartmouth, USA.<br/><br/>Michael C. Higgins is Adjunct Professor at the Stanford Center for Biomedical Informatics Research, Stanford University, USA.<br/><br/>Douglas K. Owens is a general internist and Professor and Chair of the Department of Health Policy, School of Medicine, and Director of Stanford Health Policy, Freeman-Spogli Institute for International Studies, Stanford University, USA.<br/><br/>Gillian Sanders Schmidler is Professor of Population Health Sciences and Medicine at Duke University and Deputy Director of the Duke-Margolis Institute for Health Policy, Durham, USA.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Clinical medicine
General subdivision Decision making.
Authority record control number https://id.loc.gov/authorities/subjects/sh98001051.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Diagnosis
Authority record control number https://id.loc.gov/authorities/subjects/sh85037489
General subdivision Decision making.
Authority record control number https://id.loc.gov/authorities/subjects/sh99005493.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Diagnosis, Differential.
Authority record control number https://id.loc.gov/authorities/subjects/sh85037493.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Decision making.
Authority record control number https://id.loc.gov/authorities/subjects/sh85036199.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Decision making
General subdivision Mathematical models.
Authority record control number https://id.loc.gov/authorities/subjects/sh85036200.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Probabilities.
Authority record control number https://id.loc.gov/authorities/subjects/sh85107090.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cost effectiveness.
Authority record control number https://id.loc.gov/authorities/subjects/sh85033197.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Decision Making.
Authority record control number https://id.nlm.nih.gov/mesh/D003657.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Probability.
Authority record control number https://id.nlm.nih.gov/mesh/D011336.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cost-Benefit Analysis.
Authority record control number https://id.nlm.nih.gov/mesh/D003362.
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Clinical Decision-Making.
Authority record control number https://id.nlm.nih.gov/mesh/D000066491.
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Diagnosis, Differential.
Authority record control number https://id.nlm.nih.gov/mesh/D003937.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Decision Support Techniques.
Authority record control number https://id.nlm.nih.gov/mesh/D003661.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Higgins, Michael C.
Fuller form of name (Michael Clark),
Dates associated with a name 1950-
Authority record control number https://id.loc.gov/authorities/names/n2012190181
Relator term author.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Owens, Douglas K.,
Authority record control number https://id.loc.gov/authorities/names/n2004123814
Relator term author.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sanders Schmidler, Gillian,
Authority record control number https://id.loc.gov/authorities/names/n2011183147
Relator term author.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier https://onlinelibrary.wiley.com/doi/book/10.1002/9781119627876
Link text Full text is available at Wiley Online Library Click here to view
942 ## - ADDED ENTRY ELEMENTS
Source of classification or shelving scheme
Item type EBOOK
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Permanent Location Current Location Date acquired Source of acquisition Full call number Date last seen Price effective from Item type
          COLLEGE LIBRARY COLLEGE LIBRARY 2025-07-05 ALBASA Consortium 616.07/5 2025-07-05 2025-07-05 EBOOK